Upfront surgery

PROCEDURE2 trials

Sponsors

Seoul National University Hospital, Elisabethinen Hospital

Conditions

Circulating Tumor CellPancreatic CancerPredictive Cancer Model

Phase 2

Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer

CompletedNCT01458717

Seoul National University HospitalPancreatic Cancer

Start: 2011-11-30End: 2018-01-31Updated: 2018-05-02

Phase 3

Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery

RecruitingNCT06391892

Elisabethinen HospitalCirculating Tumor Cell, Pancreatic Cancer, Predictive Cancer Model

Start: 2024-01-11End: 2026-12-31Target: 100Updated: 2024-04-30